| Hormone replacement therapy and epithelial ovarian cancer: is there and association? | |
| | |
MedLine Citation:
|
PMID: 12844427 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Recently it was estimated that about one-third of postmenopausal British women aged 50-64 years currently uses hormone replacement therapy (HRT) for treatment of climacteric symptoms and for other medical reasons. To reduce an excess risk of endometrial cancer induced by oestrogens, modern HRT regimens contain either sequential or continuous progestogens. The protective effect of parity and oral contraceptive use observed in the majority of epidemiological studies on epithelial ovarian cancer (EOC) suggest that hormonal factors are likely to operate in ovarian carcinogenesis. However, the studies where HRT was examined in relation to the risk of EOC have reported conflicting results. The objective of this epidemiological review is to evaluate the risk of EOC in relation to the use of HRT, with particular focus on the few studies where oestrogens and progestogens in HRT were assessed separately. Further, the findings regarding HRT and EOC risk will be discussed in the context of available aetiological hypotheses. Finally, any clinical implications are commented upon. |
| | |
Authors:
|
Tomas Riman |
Related Documents
:
|
17719517 - Sex differences in inappropriate prescribing among elderly veterans. 10727307 - Sex-specific differences in the treatment of severe psoriasis. 10454947 - Patient-identified needs for hormone replacement therapy counseling: a qualitative study. 9922937 - Hemophilia. a new approach to an old disease. 14696707 - Sex in australia: sexual difficulties in a representative sample of adults. 10563617 - Geographic variation of ms incidence in two prospective studies of us women. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: The journal of the British Menopause Society Volume: 9 ISSN: 1362-1807 ISO Abbreviation: J Br Menopause Soc Publication Date: 2003 Jun |
Date Detail:
|
Created Date: 2003-07-07 Completed Date: 2004-02-26 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 9815771 Medline TA: J Br Menopause Soc Country: England |
Other Details:
|
Languages: eng Pagination: 61-8 Citation Subset: IM |
Affiliation:
|
Consultant in Obstetrics and Gynaecology, Department of Obstetrics and Gynaecology, Falu Hospital, Falun, and Center for Clinical Research, Dalarna, Sweden. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Case-Control Studies Cohort Studies Estrogen Replacement Therapy / adverse effects* Female Humans Ovarian Neoplasms / epidemiology*, etiology* Risk Factors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Women's health in midlife: findings from a British birth cohort study.
Next Document: Probiotics and prebiotics in female health.